Literature DB >> 20153304

Contributions of selective knockout studies to understanding cholinesterase disposition and function.

Shelley Camp1, Limin Zhang, Eric Krejci, Alexandre Dobbertin, Véronique Bernard, Emmanuelle Girard, Ellen G Duysen, Oksana Lockridge, Antonella De Jaco, Palmer Taylor.   

Abstract

The complete knockout of the acetylcholinesterase gene (AChE) in the mouse yielded a surprising phenotype that could not have been predicted from deletion of the cholinesterase genes in Drosophila, that of a living, but functionally compromised animal. The phenotype of this animal showed a sufficient compromise in motor function that precluded precise characterization of central and peripheral nervous functional deficits. Since AChE in mammals is encoded by a single gene with alternative splicing, additional understanding of gene expression might be garnered from selected deletions of the alternatively spliced exons. To this end, transgenic strains were generated that deleted exon 5, exon 6, and the combination of exons 5 and 6. Deletion of exon 6 reduces brain AChE by 93% and muscle AChE by 72%. Deletion of exon 5 eliminates AChE from red cells and the platelet surface. These strains, as well as knockout strains that selectively eliminate the AChE anchoring protein subunits PRiMA or ColQ (which bind to sequences specified by exon 6) enabled us to examine the role of the alternatively spliced exons responsible for the tissue disposition and function of the enzyme. In addition, a knockout mouse was made with a deletion in an upstream intron that had been identified in differentiating cultures of muscle cells to control AChE expression. We found that deletion of the intronic regulatory region in the mouse essentially eliminated AChE in muscle and surprisingly from the surface of platelets. The studies generated by these knockout mouse strains have yielded valuable insights into the function and localization of AChE in mammalian systems that cannot be approached in cell culture or in vitro. Copyright (c) 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20153304      PMCID: PMC2912976          DOI: 10.1016/j.cbi.2010.02.008

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  24 in total

1.  Abundant tissue butyrylcholinesterase and its possible function in the acetylcholinesterase knockout mouse.

Authors:  B Li; J A Stribley; A Ticu; W Xie; L M Schopfer; P Hammond; S Brimijoin; S H Hinrichs; O Lockridge
Journal:  J Neurochem       Date:  2000-09       Impact factor: 5.372

2.  Transcriptional regulation of gene expression by the coding sequence: An attempt to enhance expression of human AChE.

Authors:  Claire O Weill; Sandra Vorlová; Nathalie Berna; Annick Ayon; Jean Massoulié
Journal:  Biotechnol Bioeng       Date:  2002-12-05       Impact factor: 4.530

3.  Acetylcholinesterase, choline acetyltransferase, and the postulated acetylcholine receptor of canine platelets.

Authors:  H Y Chuang; S F Mahammad; R G Mason
Journal:  Biochem Pharmacol       Date:  1976-09-01       Impact factor: 5.858

Review 4.  The cholinesterases: from genes to proteins.

Authors:  P Taylor; Z Radić
Journal:  Annu Rev Pharmacol Toxicol       Date:  1994       Impact factor: 13.820

5.  The stress-associated acetylcholinesterase variant AChE-R is expressed in human CD34(+) hematopoietic progenitors and its C-terminal peptide ARP promotes their proliferation.

Authors:  Varda R Deutsch; Marjorie Pick; Chava Perry; Dan Grisaru; Yoram Hemo; Dita Golan-Hadari; Alastair Grant; Amiram Eldor; Hermona Soreq
Journal:  Exp Hematol       Date:  2002-10       Impact factor: 3.084

6.  Respiratory survival mechanisms in acetylcholinesterase knockout mouse.

Authors:  Fabrice Chatonnet; Eliane Boudinot; Arnaud Chatonnet; Laurent Taysse; Sébastien Daulon; Jean Champagnat; Arthur S Foutz
Journal:  Eur J Neurosci       Date:  2003-09       Impact factor: 3.386

7.  Reduced acetylcholine receptor density, morphological remodeling, and butyrylcholinesterase activity can sustain muscle function in acetylcholinesterase knockout mice.

Authors:  Michael Adler; Heather A Manley; Angela L Purcell; Sharad S Deshpande; Tracey A Hamilton; Robert K Kan; George Oyler; Oksana Lockridge; Ellen G Duysen; Robert E Sheridan
Journal:  Muscle Nerve       Date:  2004-09       Impact factor: 3.217

8.  Targeting of acetylcholinesterase in neurons in vivo: a dual processing function for the proline-rich membrane anchor subunit and the attachment domain on the catalytic subunit.

Authors:  Alexandre Dobbertin; Anna Hrabovska; Korami Dembele; Shelley Camp; Palmer Taylor; Eric Krejci; Véronique Bernard
Journal:  J Neurosci       Date:  2009-04-08       Impact factor: 6.167

9.  G4 forms of acetylcholinesterase and butyrylcholinesterase in normal and dystrophic mouse muscle differ in their interaction with Ricinus communis agglutinin.

Authors:  J Cabezas-Herrera; M T Moral-Naranjo; F J Campoy; C J Vidal
Journal:  Biochim Biophys Acta       Date:  1994-02-22

10.  Gene structure of mammalian acetylcholinesterase. Alternative exons dictate tissue-specific expression.

Authors:  Y Li; S Camp; T L Rachinsky; D Getman; P Taylor
Journal:  J Biol Chem       Date:  1991-12-05       Impact factor: 5.157

View more
  9 in total

Review 1.  Neuronal AChE splice variants and their non-hydrolytic functions: redefining a target of AChE inhibitors?

Authors:  M Zimmermann
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

2.  Naturally occurring variations in the human cholinesterase genes: heritability and association with cardiovascular and metabolic traits.

Authors:  Anne M Valle; Zoran Radic; Brinda K Rana; Vafa Mahboubi; Jennifer Wessel; Pei-an Betty Shih; Fangwen Rao; Daniel T O'Connor; Palmer Taylor
Journal:  J Pharmacol Exp Ther       Date:  2011-04-14       Impact factor: 4.030

Review 3.  New pharmacological approaches to the cholinergic system: an overview on muscarinic receptor ligands and cholinesterase inhibitors.

Authors:  Nigel H Greig; Marcella Reale; Ada M Tata
Journal:  Recent Pat CNS Drug Discov       Date:  2013-08

4.  Planarian cholinesterase: molecular and functional characterization of an evolutionarily ancient enzyme to study organophosphorus pesticide toxicity.

Authors:  Danielle Hagstrom; Siqi Zhang; Alicia Ho; Eileen S Tsai; Zoran Radić; Aryo Jahromi; Kelson J Kaj; Yingtian He; Palmer Taylor; Eva-Maria S Collins
Journal:  Arch Toxicol       Date:  2017-11-22       Impact factor: 5.153

5.  Cholinergic signaling in the hippocampus regulates social stress resilience and anxiety- and depression-like behavior.

Authors:  Yann S Mineur; Adetokunbo Obayemi; Mattis B Wigestrand; Gianna M Fote; Cali A Calarco; Alice M Li; Marina R Picciotto
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-11       Impact factor: 11.205

6.  Construction and characterization of tetH overexpression and knockout strains of Acidithiobacillus ferrooxidans.

Authors:  Yangyang Yu; Xiangmei Liu; Huiyan Wang; Xiuting Li; Jianqun Lin
Journal:  J Bacteriol       Date:  2014-04-11       Impact factor: 3.490

7.  Trans-acting factors governing acetylcholinesterase mRNA metabolism in neurons.

Authors:  Lucas M Bronicki; Bernard J Jasmin
Journal:  Front Mol Neurosci       Date:  2012-03-22       Impact factor: 5.639

8.  Dysregulated Homeostasis of Acetylcholine Levels in Immune Cells of RR-Multiple Sclerosis Patients.

Authors:  Maria Di Bari; Marcella Reale; Marta Di Nicola; Viviana Orlando; Sabrina Galizia; Italo Porfilio; Erica Costantini; Chiara D'Angelo; Serena Ruggieri; Stefano Biagioni; Claudio Gasperini; Ada Maria Tata
Journal:  Int J Mol Sci       Date:  2016-11-30       Impact factor: 5.923

9.  Butyrylcholinesterase and Acetylcholinesterase polymorphisms in Multiple Sclerosis patients: implication in peripheral inflammation.

Authors:  Marcella Reale; Erica Costantini; Marta Di Nicola; Chiara D'Angelo; Sara Franchi; Marco D'Aurora; Maria Di Bari; Viviana Orlando; Sabrina Galizia; Serena Ruggieri; Liborio Stuppia; Claudio Gasperini; Ada Maria Tata; Valentina Gatta
Journal:  Sci Rep       Date:  2018-01-22       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.